IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $686 | +18.7% | 60 | 0.0% | 0.00% | – |
Q3 2023 | $578 | -56.2% | 60 | -51.6% | 0.00% | – |
Q2 2023 | $1,319 | +109.0% | 124 | +106.7% | 0.00% | – |
Q1 2023 | $631 | -15.1% | 60 | 0.0% | 0.00% | – |
Q4 2022 | $743 | -25.7% | 60 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 60 | -33.3% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 90 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 90 | +50.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | – | 60 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 60 | -25.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 80 | -14.0% | 0.00% | -100.0% |
Q4 2019 | $1,000 | 0.0% | 93 | -31.1% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 135 | +3.8% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 130 | -11.6% | 0.00% | – |
Q1 2019 | $2,000 | – | 147 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |